The document evaluates different binders for use in moist aqueous granulation (MAG) formulations of high-dose metformin HCL. Four binders - vinylpyrrolidone-vinyl acetate copolymer, polyvidone, hydroxypropyl cellulose, and hydroxypropyl methylcellulose - were tested. Granules made with hydroxypropyl methylcellulose were not sufficiently granulated with a low water volume. Granules containing hydroxypropyl cellulose had a tendency to form bowls during tableting, while those with polyvidone tended to stick. Vinylpyrrolidone-vinyl acetate copolymer granules maintained proper moisture balance and flow the best. The type of binder used
This document describes research into developing a new formulation map for high-shear wet granulation processes using on-line torque measurements. The researchers conducted experiments varying formulation parameters like binder type and amount, as well as diluent particle size, to determine the minimum liquid volume needed for granule growth. They found that granulation onset, identified by an abrupt increase in torque, requires the liquid added to exceed a minimum threshold volume. This minimum liquid volume depends on factors like the dry binder type, amount, and diluent properties. They also showed this formulation map could be constructed using independent measurements of binder glass transition temperatures under different humidity conditions.
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Merck Life Sciences
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Valentyn Mohylyuk
Suspension of microparticles in an easy-to-swallow liquid is one approach to develop sustained-release formulations for children and patients with swallowing difficulties. However, to date production of sustained-release microparticles at the industrial scale has proven to be challenging. The aim of this investigation was to develop an innovative concept in coating sustained-release microparticles using industrial scalable Wurster fluidised bed to produce oral liquid suspensions. Microcrystalline cellulose cores (particle size <150 μm) were coated with Eudragit® NM 30 D and Eudragit® RS/RL 30 D aqueous dispersions using a fluidised bed coater. A novel approach of periodic addition of a small quantity (0.1% w/w) of dry powder glidant, magnesium stearate, to the coating chamber via an external port was applied throughout the coating process. This method significantly increased coating production yield from less than 50% to up to 99% compared to conventional coating
process without the dry powder glidant. Powder rheology tests showed that dry powder glidants increased the tapped density and decreased the cohesive index of coated microparticles. Reproducible microencapsulation of a highly water-soluble drug, metoprolol succinate, was achieved, yielding coated microparticles less than 200 μm in size with 20-h sustained drug release, suitable for use in liquid suspensions. The robust, scalable technology presented in this study offers an important solution to the long-standing challenges of formulating sustained-release dosage forms suitable for children and older people with swallowing difficulties.
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
Formulation and Evaluation of Controlled Release Tablet of LamotrigineBRNSS Publication Hub
This document describes the formulation and evaluation of controlled release tablets containing lamotrigine using solid dispersions. Lamotrigine is poorly water soluble, so solid dispersions were developed using polymers like Eudragit and PVP to improve its solubility and develop controlled release tablets. The polymers and drug were combined using methods like solvent evaporation to form amorphous solid dispersions. Tablets were prepared from these solid dispersions and evaluated for properties like drug release and micromeritic behavior. X-ray diffraction studies confirmed the amorphous nature of optimized solid dispersions. Overall, the study developed lamotrigine controlled release tablets using solid dispersions to enhance its solubility and provide controlled drug release.
2017. Micropellets coated with Kollicoat Smartseal 30 D (Full version)Valentyn Mohylyuk
This research article describes developing liquid oral suspensions for taste masking bitter drugs using micropellets coated with KollicoatVR Smartseal 30D. Coating micropellets containing bitter drugs like quinine sulfate and diclofenac sodium with KollicoatVR Smartseal 30D reduced drug leaching into aqueous medium, especially at higher pH, providing taste masking. Adding an ion exchange resin layer between the drug layer and coating further decreased drug leaching. Optimized liquid vehicles with added sugar alcohols and ion exchange resin allowed developing reconstitutable or ready-to-use liquid dosage forms that maintained bitter taste protection for over 3 weeks when redispersed.
Formulation and evaluation of effervescent tablets.pptxParimal Hadge
This document discusses the formulation and evaluation of effervescent tablets. It begins by defining effervescent tablets as tablets intended to be dissolved or dispersed in water before administration. They generally contain acid substances that react with carbonates or bicarbonates to release carbon dioxide when exposed to water. The document then outlines the advantages of effervescent tablets such as fast onset of action and improved palatability. It provides details on common active ingredients, preparation methods, ingredients used, manufacturing techniques, and evaluation parameters for effervescent tablets including disintegration time, dissolution testing, and content uniformity.
This document describes research into developing a new formulation map for high-shear wet granulation processes using on-line torque measurements. The researchers conducted experiments varying formulation parameters like binder type and amount, as well as diluent particle size, to determine the minimum liquid volume needed for granule growth. They found that granulation onset, identified by an abrupt increase in torque, requires the liquid added to exceed a minimum threshold volume. This minimum liquid volume depends on factors like the dry binder type, amount, and diluent properties. They also showed this formulation map could be constructed using independent measurements of binder glass transition temperatures under different humidity conditions.
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Merck Life Sciences
Hot melt extrusion has successfully emerged as an innovative manufacturing technology in pharmaceutical industry for the creation of amorphous solid dispersions (ASDs).
In this webinar you will learn about the potential of hot melt extrusion to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA) as a matrix polymer. We will provide an overview about different types of solid dispersions and their evolution in the pharmaceutical field. A brief introduction in hot melt extrusion processing will be given as well as actual formulation trends. You will get insights in potential down-stream options to create your final dosage form and you will gain ideas on how to speed up your formulation development.
A detailed background of PVA will be provided including its physical properties as well as its regulatory status. PVA is more than a polymer. Due to its amphiphilic structure it has the potential to improve the supersaturation of low soluble APIs and to prevent precipitation after release. This highlights the versatility of PVA as an advanced polymer for HME applications and we will guide you through our latest research activities so that you can leverage our knowledge to improve your formulations.
This webinar includes:
- The current status and further potential of HME in pharmaceutical industry
- Advantages of PVA in the field of ASDs: Solubility improvement, impact on supersaturation potential, stability data generated on sample formulations & downstream options
- Deep dive into latest research activities: Permeation studies with Caco-2 cell membranes, pH shift studies to investigate supersaturation potential, ongoing research activities to get to know a more detailed understanding of matrix systems and their intermolecular interactions
In this webinar, you will learn:
- which potential hot melt extrusion has, to overcome challenges in API solubility and bioavailability by using polyvinyl alcohol (PVA)
- why PVA is more than just a polymer
- how to create your final dosage form and speed up your formulation development
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Valentyn Mohylyuk
Suspension of microparticles in an easy-to-swallow liquid is one approach to develop sustained-release formulations for children and patients with swallowing difficulties. However, to date production of sustained-release microparticles at the industrial scale has proven to be challenging. The aim of this investigation was to develop an innovative concept in coating sustained-release microparticles using industrial scalable Wurster fluidised bed to produce oral liquid suspensions. Microcrystalline cellulose cores (particle size <150 μm) were coated with Eudragit® NM 30 D and Eudragit® RS/RL 30 D aqueous dispersions using a fluidised bed coater. A novel approach of periodic addition of a small quantity (0.1% w/w) of dry powder glidant, magnesium stearate, to the coating chamber via an external port was applied throughout the coating process. This method significantly increased coating production yield from less than 50% to up to 99% compared to conventional coating
process without the dry powder glidant. Powder rheology tests showed that dry powder glidants increased the tapped density and decreased the cohesive index of coated microparticles. Reproducible microencapsulation of a highly water-soluble drug, metoprolol succinate, was achieved, yielding coated microparticles less than 200 μm in size with 20-h sustained drug release, suitable for use in liquid suspensions. The robust, scalable technology presented in this study offers an important solution to the long-standing challenges of formulating sustained-release dosage forms suitable for children and older people with swallowing difficulties.
The document discusses co-processed excipients, which are combinations of two or more excipients designed to physically modify their properties without chemical change. It defines co-processed excipients and provides examples such as microcrystalline cellulose and mannitol. The document outlines the need for co-processed excipients, their manufacturing principles and processes like spray drying. It also discusses the advantages of co-processed excipients in improving flow properties and compressibility as well as their applications and evaluation parameters.
Formulation and Evaluation of Controlled Release Tablet of LamotrigineBRNSS Publication Hub
This document describes the formulation and evaluation of controlled release tablets containing lamotrigine using solid dispersions. Lamotrigine is poorly water soluble, so solid dispersions were developed using polymers like Eudragit and PVP to improve its solubility and develop controlled release tablets. The polymers and drug were combined using methods like solvent evaporation to form amorphous solid dispersions. Tablets were prepared from these solid dispersions and evaluated for properties like drug release and micromeritic behavior. X-ray diffraction studies confirmed the amorphous nature of optimized solid dispersions. Overall, the study developed lamotrigine controlled release tablets using solid dispersions to enhance its solubility and provide controlled drug release.
2017. Micropellets coated with Kollicoat Smartseal 30 D (Full version)Valentyn Mohylyuk
This research article describes developing liquid oral suspensions for taste masking bitter drugs using micropellets coated with KollicoatVR Smartseal 30D. Coating micropellets containing bitter drugs like quinine sulfate and diclofenac sodium with KollicoatVR Smartseal 30D reduced drug leaching into aqueous medium, especially at higher pH, providing taste masking. Adding an ion exchange resin layer between the drug layer and coating further decreased drug leaching. Optimized liquid vehicles with added sugar alcohols and ion exchange resin allowed developing reconstitutable or ready-to-use liquid dosage forms that maintained bitter taste protection for over 3 weeks when redispersed.
Formulation and evaluation of effervescent tablets.pptxParimal Hadge
This document discusses the formulation and evaluation of effervescent tablets. It begins by defining effervescent tablets as tablets intended to be dissolved or dispersed in water before administration. They generally contain acid substances that react with carbonates or bicarbonates to release carbon dioxide when exposed to water. The document then outlines the advantages of effervescent tablets such as fast onset of action and improved palatability. It provides details on common active ingredients, preparation methods, ingredients used, manufacturing techniques, and evaluation parameters for effervescent tablets including disintegration time, dissolution testing, and content uniformity.
The document discusses regulatory guidelines regarding polymorphs and cocrystals. It begins by defining polymorphs as crystalline, amorphous, solvate, and hydrate forms of a drug substance that have different molecular arrangements. It then discusses how polymorphism can impact properties like solubility, dissolution, bioavailability, and stability. The document also summarizes the "Ritonavir Story" which demonstrated these issues and prompted regulatory guidelines. It outlines the FDA guidance for assessing polymorphism in ANDAs, including decision trees for drug substances and products. Finally, it defines cocrystals and the characterization needed to demonstrate they are pharmaceutical cocrystals rather than salts.
Stability studies during different stages of drug and product development.pptxParimal Hadge
The document discusses stability testing guidelines for drug substances and products during development and registration. It outlines the objectives to provide evidence on quality changes over time under various environmental factors and establish a re-test period or shelf life. For drug substances, it describes stress testing, selection of batches, specifications and storage conditions for long term, accelerated and intermediate testing. For drug products, it discusses photostability testing, batch selection, specifications, storage conditions and criteria for significant changes during stability testing.
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
The document discusses the formulation and evaluation of solid dispersions of the drug carvedilol to improve its solubility and dissolution rate. Carvedilol was selected as it has low aqueous solubility and bioavailability. Solid dispersions were prepared using different carriers like poloxamer 407, mannitol, and PEG 4000 via solvent evaporation method. The dispersions were evaluated for dissolution rate and the best formulation was selected based on the evaluation studies. Stability studies were also proposed to be conducted on the best formulation.
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...Sagar Savale
The Metformin HCL Micro Beads is formulated by the Ionotropic Gelation Method. The CMC is a Swellable
polymer is responsible for the Sustained release action or activity. A combination of CMC (Carboxy Methyl
Cellulose) and Sodium Alginate shows better sustained release activity. The PreparedSustained released Micro
Beadsis Evaluated In terms of bulk density, tapped density, angle of repose, Carr’s Index, Swelling Index, Drug
Content, % Encapsulation Efficiency and vitro study. The result associated in Optimized batch is good to
Satisfactory and having a good free flowing property. The Drug Content and % Encapsulation Efficiency values are
within the pharmacopeia limit. The in vitro Dissolution studies shows Maximum percentage of release of drug
(71.15) with in end of 4 Hours.
Formulation and evaluation of metformin and rosuvastatin bilayered tabletsSriramNagarajan17
This document describes the formulation and evaluation of bilayer tablets containing metformin hydrochloride as the sustained release layer and rosuvastatin as the immediate release layer. Various formulations of each layer were prepared using different polymers, excipients, and manufacturing methods. The metformin layer was prepared by wet granulation while the rosuvastatin layer used direct compression. Physicochemical properties of granules and tablets were evaluated. Standard calibration curves were developed for both drugs to enable drug content analysis. The optimized formulations demonstrated desired drug release profiles with the metformin layer providing sustained release over 12 hours and the rosuvastatin layer releasing completely within 1 hour.
Eudragits are acrylic and methacrylic acid copolymers that are used in pharmaceutical applications for controlled drug release. Different Eudragit polymers allow targeted drug release in various parts of the gastrointestinal tract depending on their pH-dependent solubility. Eudragit polymers can be used to coat formulations for enteric delivery to protect drugs from gastric fluid, or for sustained release in the intestines through diffusion or matrix mechanisms. Common Eudragit grades like Eudragit L, S, and FS are suitable for enteric coatings, while Eudragit RL, RS, and NE polymers are used for sustained release formulations.
This document discusses using gelatin beads as a sustained release drug delivery system. Gelatin beads can provide sustained release of drugs over time by taking advantage of their large surface area and diffusion properties. The document describes preparing and evaluating propranolol HCl loaded gelatin beads using natural polymers gelatin and fish gelatin crosslinked with glutaraldehyde. The beads were evaluated for loading efficiency, yield, in vitro drug release, and stability over 3 months of accelerated conditions. Overall, the document proposes that gelatin beads can serve as a biocompatible drug delivery system for sustained drug release.
Extrusion is a process used to create new materials with desirable properties. Recent advances in hot melt extrusion (HME) technology include using lower processing temperatures, pressurized carbon dioxide as a reversible plasticizer, and coupling HME with other technologies like 3D printing. Case studies demonstrated how HME can produce formulations with content uniformity at low doses and how pressurized carbon dioxide can affect the properties of ketoprofen formulations. Overall, HME is a continuous process that is being advanced to overcome weaknesses and expand its applications in pharmaceutical manufacturing.
The document presents an abstract for developing orally disintegrating tablets using microwave technology. Microwave technology applies the principle of heating polar molecules through vibration to generate pores in tablets for rapid disintegration, without compromising hardness. A bitter drug was complexed with beta-cyclodextrin to enhance solubility and mask bitterness. Tablets were prepared conventionally and exposed to humidity and microwaves to form pores. Crosspovidone was identified as the optimal superdisintegrant. A 23 factorial design was used to optimize the formulation's critical quality attributes of disintegration time and hardness based on superdisintegrant concentration and humidity/microwave exposure times. The optimized formulation showed a disintegration time of 23 seconds and hardness of
Formulation and Evaluation of Gabapentin Mucoadhesive Gastro Retentive Tablets.pharmaindexing
This document describes the formulation and evaluation of gabapentin mucoadhesive gastroretentive tablets. Various tablet formulations were prepared using different concentrations of mucoadhesive polymers like carbopol 934P, sodium CMC, and sodium alginate. The tablets were evaluated for parameters like thickness, weight variation, hardness, drug content, swelling index, and mucoadhesive strength. In vitro drug release studies showed that a formulation containing 0.5% carbopol 934P (F-IV) exhibited slowest drug release over 12 hours compared to other formulations. Stability studies of F-IV showed no significant changes in properties after 3 months of storage. The study concluded that mucoadhesive polymers can help
ABSTRACT
Hyperglycemia is the technical term for high blood glucose (sugar). It
happens when the body has too little or not enough insulin or when the
body can‘t use insulin properly. The main objective of the present
research work was to develop a bilayer tablet of immediate release
Pioglitazone and controlled release Metformin Hydrochloride, which is
used as an Anti-hyperglycemic agent. Metformin Hydrochloride has
biological half-life nearly about 6 hours, so, an attempt was made in
the direction of preparation and optimization of a combination of
sustained release and immediate release in a single tablet. In controlled
release layer natural gums like xanthum gum, gum trgacanth and guar
gum were used as retarding materials and in immediate release laye
croscarmellose sodium was used as a superdisintegrent to give the faster release of
pioglitazone. The tablets were prepared by wet granulation method and by direct
compression. Granules were evaluated for precompression parameters and the tablets were
evaluated for post compression parameters.
Key Words: Bilayer tablets, Metformin Hydrochloride, pioglitazone, xanthum gum, guar
gum, gum tragacanth and crosscarmellose sodium.
This document describes the development and evaluation of bilayer tablets containing capecitabine and ondansetron. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology, providing sustained release of capecitabine in one layer and immediate release of ondansetron in another layer. Various excipients were evaluated to optimize the drug release profiles from each layer. Pre-formulation studies and tablet evaluations were conducted to develop a cost-effective bilayer tablet formulation for once-daily treatment of nausea and vomiting.
Formulation and evaluation of matrix type rosuvastatin sustained release tabletspharmaindexing
This document describes the formulation and evaluation of matrix-type sustained release tablets of rosuvastatin. Tablets were prepared using polymers like HPMC K15M, HPMC K50M, and ethylcellulose by direct compression technique. The tablets were evaluated for characteristics like hardness, thickness, friability, weight variation, drug content, and floating properties. The best formulation was subjected to kinetic treatment and was found to follow zero order, first order, Peppas, Higuchi, and Hixson-Crowell kinetics. The optimized batches were stable for 2 months at 40°C/75% RH conditions. The document provides details on various sustained release drug delivery systems, techniques for tablet formulation like direct compression
The document summarizes research on developing enteric-coated tablets of the drug Ramipril to improve its bioavailability and reduce side effects. Immediate-release core tablets were prepared with different superdisintegrants and coated with pH-sensitive polymers Eudragit L-100 and Cellulose Acetate Pthalate. Tablets coated with 9% Cellulose Acetate Pthalate at a coating ratio of 60% triethyl citrate and IPA:DCM 60:40 provided the highest drug release profile in dissolution testing. The optimized formulation aims to protect Ramipril from degradation in the stomach and provide rapid drug release in the intestines.
The document discusses solid dispersion and complexation techniques for improving the solubility and bioavailability of poorly soluble drugs. Solid dispersion involves combining a drug with a hydrophilic carrier to improve its dissolution rate. Types of solid dispersions include solid solutions, eutectic mixtures, and glass suspensions. Preparation techniques include hot melt, solvent evaporation, melt extrusion, and kneading. Complexation, such as drug-cyclodextrin inclusion complexes, enhances drug solubility and stability. These techniques are important for formulating oral drugs that are limited by poor solubility.
Improved and Novel Excipients – Need, sources of new excipients-co-processing and particle engineering, benefits of co-processed excipients, characterization, examples, regulatory aspects
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...Ajinkya Nikam
1) Solid dispersion is a method to improve the solubility of poorly water soluble drugs by dispersing drugs in a hydrophilic carrier. It involves mixing the drug with a carrier on a molecular or microscopic level.
2) Common methods for preparing solid dispersions include fusion, solvent evaporation, spray drying, and melt extrusion. These methods aim to convert crystalline drugs into amorphous forms within hydrophilic carriers.
3) Characterization techniques like DSC, XRD, and dissolution testing are used to analyze the molecular state of drugs in solid dispersions and evaluate increases in solubility and dissolution rate compared to raw drugs.
Tapioca starch-pullulan interaction during gelation and retrogradationMostafa Gouda
The interaction between pullulan (PU) and tapioca starch (TS) during gelatinization and retrogradation was
studied in this paper. TS and PU were prepared into a TS/PU composite system at the ratios of 10/0, 9.5/0.5,
9.0/1.0, 8.5/1.5 and 8.0/2.0 g/g. The addition of PU tended to decrease the peak, breakdown and final viscosity
of the composite system. The increasing tanδ of the dynamic viscoelastic measurement suggested that PU enhanced
the liquid-like properties of TS gels. The decreased setback values and the slower increase of the storage
modulus at 4 °C indicated that the short-term retrogradation of TS was restrained. Meanwhile, the peaks of X-ray
diffraction became lower and wider, revealing that PU could inhibit the long-term retrogradation of TS. The FTIR
spectra showed that the absorption peak of the O−H stretching gradually redshifted with increasing PU content,
suggesting that a strong intermolecular hydrogen binding occurred between TS and PU. From low-field nuclear
magnetic resonance, the spin-spin relaxation time decreased from 1687 ms (TS/PU=10.0/0) to 1427 ms (TS/
PU=8.0/2.0), illustrating that the addition of PU promotes the water retention ability of the TS paste.
Therefore, PU had an effect on TS gelatinization and retrogradation.
The document discusses various granulation technologies used in pharmaceutical manufacturing. It begins with describing the ideal characteristics of granules and reasons for granulation. Then it discusses several novel granulation technologies including pneumatic dry granulation, freeze granulation, foamed binder technologies, melt granulation, steam granulation, and moisture activated dry granulation. Each technology is briefly described in terms of its process, advantages, and applications. The document emphasizes that pneumatic dry granulation can granulate any pharmaceutical ingredient and has advantages over traditional wet granulation methods.
The document discusses regulatory guidelines regarding polymorphs and cocrystals. It begins by defining polymorphs as crystalline, amorphous, solvate, and hydrate forms of a drug substance that have different molecular arrangements. It then discusses how polymorphism can impact properties like solubility, dissolution, bioavailability, and stability. The document also summarizes the "Ritonavir Story" which demonstrated these issues and prompted regulatory guidelines. It outlines the FDA guidance for assessing polymorphism in ANDAs, including decision trees for drug substances and products. Finally, it defines cocrystals and the characterization needed to demonstrate they are pharmaceutical cocrystals rather than salts.
Stability studies during different stages of drug and product development.pptxParimal Hadge
The document discusses stability testing guidelines for drug substances and products during development and registration. It outlines the objectives to provide evidence on quality changes over time under various environmental factors and establish a re-test period or shelf life. For drug substances, it describes stress testing, selection of batches, specifications and storage conditions for long term, accelerated and intermediate testing. For drug products, it discusses photostability testing, batch selection, specifications, storage conditions and criteria for significant changes during stability testing.
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
The document discusses the formulation and evaluation of solid dispersions of the drug carvedilol to improve its solubility and dissolution rate. Carvedilol was selected as it has low aqueous solubility and bioavailability. Solid dispersions were prepared using different carriers like poloxamer 407, mannitol, and PEG 4000 via solvent evaporation method. The dispersions were evaluated for dissolution rate and the best formulation was selected based on the evaluation studies. Stability studies were also proposed to be conducted on the best formulation.
Formulation and evaluation ofmetformin HCl micro beads by ionotropic gelation...Sagar Savale
The Metformin HCL Micro Beads is formulated by the Ionotropic Gelation Method. The CMC is a Swellable
polymer is responsible for the Sustained release action or activity. A combination of CMC (Carboxy Methyl
Cellulose) and Sodium Alginate shows better sustained release activity. The PreparedSustained released Micro
Beadsis Evaluated In terms of bulk density, tapped density, angle of repose, Carr’s Index, Swelling Index, Drug
Content, % Encapsulation Efficiency and vitro study. The result associated in Optimized batch is good to
Satisfactory and having a good free flowing property. The Drug Content and % Encapsulation Efficiency values are
within the pharmacopeia limit. The in vitro Dissolution studies shows Maximum percentage of release of drug
(71.15) with in end of 4 Hours.
Formulation and evaluation of metformin and rosuvastatin bilayered tabletsSriramNagarajan17
This document describes the formulation and evaluation of bilayer tablets containing metformin hydrochloride as the sustained release layer and rosuvastatin as the immediate release layer. Various formulations of each layer were prepared using different polymers, excipients, and manufacturing methods. The metformin layer was prepared by wet granulation while the rosuvastatin layer used direct compression. Physicochemical properties of granules and tablets were evaluated. Standard calibration curves were developed for both drugs to enable drug content analysis. The optimized formulations demonstrated desired drug release profiles with the metformin layer providing sustained release over 12 hours and the rosuvastatin layer releasing completely within 1 hour.
Eudragits are acrylic and methacrylic acid copolymers that are used in pharmaceutical applications for controlled drug release. Different Eudragit polymers allow targeted drug release in various parts of the gastrointestinal tract depending on their pH-dependent solubility. Eudragit polymers can be used to coat formulations for enteric delivery to protect drugs from gastric fluid, or for sustained release in the intestines through diffusion or matrix mechanisms. Common Eudragit grades like Eudragit L, S, and FS are suitable for enteric coatings, while Eudragit RL, RS, and NE polymers are used for sustained release formulations.
This document discusses using gelatin beads as a sustained release drug delivery system. Gelatin beads can provide sustained release of drugs over time by taking advantage of their large surface area and diffusion properties. The document describes preparing and evaluating propranolol HCl loaded gelatin beads using natural polymers gelatin and fish gelatin crosslinked with glutaraldehyde. The beads were evaluated for loading efficiency, yield, in vitro drug release, and stability over 3 months of accelerated conditions. Overall, the document proposes that gelatin beads can serve as a biocompatible drug delivery system for sustained drug release.
Extrusion is a process used to create new materials with desirable properties. Recent advances in hot melt extrusion (HME) technology include using lower processing temperatures, pressurized carbon dioxide as a reversible plasticizer, and coupling HME with other technologies like 3D printing. Case studies demonstrated how HME can produce formulations with content uniformity at low doses and how pressurized carbon dioxide can affect the properties of ketoprofen formulations. Overall, HME is a continuous process that is being advanced to overcome weaknesses and expand its applications in pharmaceutical manufacturing.
The document presents an abstract for developing orally disintegrating tablets using microwave technology. Microwave technology applies the principle of heating polar molecules through vibration to generate pores in tablets for rapid disintegration, without compromising hardness. A bitter drug was complexed with beta-cyclodextrin to enhance solubility and mask bitterness. Tablets were prepared conventionally and exposed to humidity and microwaves to form pores. Crosspovidone was identified as the optimal superdisintegrant. A 23 factorial design was used to optimize the formulation's critical quality attributes of disintegration time and hardness based on superdisintegrant concentration and humidity/microwave exposure times. The optimized formulation showed a disintegration time of 23 seconds and hardness of
Formulation and Evaluation of Gabapentin Mucoadhesive Gastro Retentive Tablets.pharmaindexing
This document describes the formulation and evaluation of gabapentin mucoadhesive gastroretentive tablets. Various tablet formulations were prepared using different concentrations of mucoadhesive polymers like carbopol 934P, sodium CMC, and sodium alginate. The tablets were evaluated for parameters like thickness, weight variation, hardness, drug content, swelling index, and mucoadhesive strength. In vitro drug release studies showed that a formulation containing 0.5% carbopol 934P (F-IV) exhibited slowest drug release over 12 hours compared to other formulations. Stability studies of F-IV showed no significant changes in properties after 3 months of storage. The study concluded that mucoadhesive polymers can help
ABSTRACT
Hyperglycemia is the technical term for high blood glucose (sugar). It
happens when the body has too little or not enough insulin or when the
body can‘t use insulin properly. The main objective of the present
research work was to develop a bilayer tablet of immediate release
Pioglitazone and controlled release Metformin Hydrochloride, which is
used as an Anti-hyperglycemic agent. Metformin Hydrochloride has
biological half-life nearly about 6 hours, so, an attempt was made in
the direction of preparation and optimization of a combination of
sustained release and immediate release in a single tablet. In controlled
release layer natural gums like xanthum gum, gum trgacanth and guar
gum were used as retarding materials and in immediate release laye
croscarmellose sodium was used as a superdisintegrent to give the faster release of
pioglitazone. The tablets were prepared by wet granulation method and by direct
compression. Granules were evaluated for precompression parameters and the tablets were
evaluated for post compression parameters.
Key Words: Bilayer tablets, Metformin Hydrochloride, pioglitazone, xanthum gum, guar
gum, gum tragacanth and crosscarmellose sodium.
This document describes the development and evaluation of bilayer tablets containing capecitabine and ondansetron. The bilayer tablet uses Dual Release Drug Absorption System (DUREDAS) technology, providing sustained release of capecitabine in one layer and immediate release of ondansetron in another layer. Various excipients were evaluated to optimize the drug release profiles from each layer. Pre-formulation studies and tablet evaluations were conducted to develop a cost-effective bilayer tablet formulation for once-daily treatment of nausea and vomiting.
Formulation and evaluation of matrix type rosuvastatin sustained release tabletspharmaindexing
This document describes the formulation and evaluation of matrix-type sustained release tablets of rosuvastatin. Tablets were prepared using polymers like HPMC K15M, HPMC K50M, and ethylcellulose by direct compression technique. The tablets were evaluated for characteristics like hardness, thickness, friability, weight variation, drug content, and floating properties. The best formulation was subjected to kinetic treatment and was found to follow zero order, first order, Peppas, Higuchi, and Hixson-Crowell kinetics. The optimized batches were stable for 2 months at 40°C/75% RH conditions. The document provides details on various sustained release drug delivery systems, techniques for tablet formulation like direct compression
The document summarizes research on developing enteric-coated tablets of the drug Ramipril to improve its bioavailability and reduce side effects. Immediate-release core tablets were prepared with different superdisintegrants and coated with pH-sensitive polymers Eudragit L-100 and Cellulose Acetate Pthalate. Tablets coated with 9% Cellulose Acetate Pthalate at a coating ratio of 60% triethyl citrate and IPA:DCM 60:40 provided the highest drug release profile in dissolution testing. The optimized formulation aims to protect Ramipril from degradation in the stomach and provide rapid drug release in the intestines.
The document discusses solid dispersion and complexation techniques for improving the solubility and bioavailability of poorly soluble drugs. Solid dispersion involves combining a drug with a hydrophilic carrier to improve its dissolution rate. Types of solid dispersions include solid solutions, eutectic mixtures, and glass suspensions. Preparation techniques include hot melt, solvent evaporation, melt extrusion, and kneading. Complexation, such as drug-cyclodextrin inclusion complexes, enhances drug solubility and stability. These techniques are important for formulating oral drugs that are limited by poor solubility.
Improved and Novel Excipients – Need, sources of new excipients-co-processing and particle engineering, benefits of co-processed excipients, characterization, examples, regulatory aspects
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...Ajinkya Nikam
1) Solid dispersion is a method to improve the solubility of poorly water soluble drugs by dispersing drugs in a hydrophilic carrier. It involves mixing the drug with a carrier on a molecular or microscopic level.
2) Common methods for preparing solid dispersions include fusion, solvent evaporation, spray drying, and melt extrusion. These methods aim to convert crystalline drugs into amorphous forms within hydrophilic carriers.
3) Characterization techniques like DSC, XRD, and dissolution testing are used to analyze the molecular state of drugs in solid dispersions and evaluate increases in solubility and dissolution rate compared to raw drugs.
Tapioca starch-pullulan interaction during gelation and retrogradationMostafa Gouda
The interaction between pullulan (PU) and tapioca starch (TS) during gelatinization and retrogradation was
studied in this paper. TS and PU were prepared into a TS/PU composite system at the ratios of 10/0, 9.5/0.5,
9.0/1.0, 8.5/1.5 and 8.0/2.0 g/g. The addition of PU tended to decrease the peak, breakdown and final viscosity
of the composite system. The increasing tanδ of the dynamic viscoelastic measurement suggested that PU enhanced
the liquid-like properties of TS gels. The decreased setback values and the slower increase of the storage
modulus at 4 °C indicated that the short-term retrogradation of TS was restrained. Meanwhile, the peaks of X-ray
diffraction became lower and wider, revealing that PU could inhibit the long-term retrogradation of TS. The FTIR
spectra showed that the absorption peak of the O−H stretching gradually redshifted with increasing PU content,
suggesting that a strong intermolecular hydrogen binding occurred between TS and PU. From low-field nuclear
magnetic resonance, the spin-spin relaxation time decreased from 1687 ms (TS/PU=10.0/0) to 1427 ms (TS/
PU=8.0/2.0), illustrating that the addition of PU promotes the water retention ability of the TS paste.
Therefore, PU had an effect on TS gelatinization and retrogradation.
The document discusses various granulation technologies used in pharmaceutical manufacturing. It begins with describing the ideal characteristics of granules and reasons for granulation. Then it discusses several novel granulation technologies including pneumatic dry granulation, freeze granulation, foamed binder technologies, melt granulation, steam granulation, and moisture activated dry granulation. Each technology is briefly described in terms of its process, advantages, and applications. The document emphasizes that pneumatic dry granulation can granulate any pharmaceutical ingredient and has advantages over traditional wet granulation methods.
Evaluating the Effects of Different Molecular Weights of Polymers in Stabiliz...Smruti Chaudhari, Ph.D.
This document evaluates the effects of different molecular weights of polymers on stabilizing supersaturated drug solutions and formulations using fenofibrate as a model drug. Three grades each of HPMC (E5, E15, E50) and PVP (K12, K29, K90) were studied using two approaches - a non-formulated drug method (solvent shift) and a formulated drug method (solvent casting and spray drying). Miniaturized testing suggested HPMC E5 and PVP K29 best extended and stabilized supersaturated solutions. Spray-dried dispersions showed polymer molecular weight and amount influenced stability, with high molecular weight polymers more stable at high drug loading, though governing dissolution.
This document provides an overview of granulation techniques used in pharmaceutical manufacturing. It defines granulation and describes common granulation methods like wet and dry granulation. Wet granulation techniques like high shear and low shear mixing are explained in detail along with novel techniques like moisture activated dry granulation, thermal adhesion granulation, and freeze granulation. Key granulation process parameters and characteristics of granules are also summarized. The document concludes by discussing various granulation technologies and their applications in the pharmaceutical industry.
Comparison Between Tablets Granulation Methods
The document compares different tablet granulation methods including wet granulation, dry granulation, and moisture activated dry granulation (MADG). MADG is described as a simple, one-pot process that creates granules using a small amount of water without the need for drying. It saves time and money compared to wet granulation by skipping drying, milling, and screening steps. MADG results in granules with good physical properties and flowability at a lower cost than conventional wet granulation.
Direct Compression is the simplest form of oral dosage production as it contains the fewest process stages, leading to a shorter process cycle and faster production times.
Technology Transfer From R and D to Pilot Plant to Plant for Non-Sterile Semi...shiv
Technology transfer is important for successful progress of drug development from research to commercialization. This presentation discusses technology transfer from research and development to pilot plant and full-scale production of non-sterile semisolids. It covers the importance of pilot plants in scale-up, factors to consider in scaling up semisolids like mixing equipment and homogenization processes. SUPAC guidelines for scale-up and post-approval changes are also summarized. A case study demonstrates issues encountered like congealing during scale-up of a cream formulation containing diethylene glycol monoethyl ether from lab to pilot scale.
Formulation and evaluation of Gastroretentive Bosentan monohydrate tablets us...mamatha jirra
The presentation is about the preparation and evaluation of Bosentan monohydrate tablets using raft technology, which is used to treat Pulmonary Arterial Hypertension (PAH). Raft technology is a novel approach to formulate Gastroretentive tablets. Raft is formed on the surface of gastric contents when the tablet comes in contact with the gastric fluid. The drug is released from the raft slowly and continuously resulting in controlled drug release.
Influence of manufacturing process on physical and flow characteristic and c...Ghazwa Shawash
REFRANCES:
1. www.pubmed.com :
(1) Garg ,A., Gupta ,M., Bhargava ,H.N.. (2007). Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. European Journal of Pharmaceutics and Biopharmaceutics. 67(3), 725-731.
(2) Närvänen ,T., Lipsanen ,T., Antikainen ,O., Räikkönen ,H.,Yliruusi ,J.. (2008). Controlling granule size by granulation liquid feed pulsing. International Journal of Pharmaceutics. 357(1-2), 132-138.
(3) Ende ,T.a.m., Moses ,K., Carella ,j., Gadkari ,A., Graul ,W., Otano ,L., Timpano ,J. .( 2007). Improving the Content Uniformity of a Low-Dose Tablet Formulation Through Roller Compaction Optimization. Pharmaceutical Development and Technology. 12(4), 391 – 404.
(4) Alkhatib ,H.S., Aiedeh ,K.M., Bustanji ,Y., Hamed ,S., Mohammad ,M.K., Alkhalidi ,B., Najjar ,S.. (2008). Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: Implications for pH-independent release. European Journal of Pharmaceutics and Biopharmaceutics.
(5) Brodka-Pfeiffer ,K., Langguth ,P., Grass ,P., Häusler ,H.. (2003). Influence of mechanical activation on the physical stability of salbutamol sulphate. European Journal of Pharmaceutics and Biopharmaceutics. 56(3), 393-400.
(6) El-Sabawi ,D., Price ,R., Edge ,S., Young ,P.M.. (2006). Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. 32(2), 243-51.
(7) Bacher ,C., Olsen ,P.M., Bertelsen ,P., Sonnergaard ,J.M.. (2008). Compressibility and compactibility of granules produced by wet and dry granulation. International Journal of Pharmaceutics. 358(1-2), 69-74.
(8) Bock ,T.K., Kraas ,U.. (2001). Experience with the Diosna mini-granulator and assessment of process scalability. European Journal of Pharmaceutics and Biopharmaceutics. 52(3), 297-303.
(9) Badawy ,S.I., Menning ,M.M., Gorko ,M.A., Gilbert ,D.L. (2000). Effect of process parameters on compressibility of granulation manufactured in a high-shear mixer. International Journal of Pharmaceutics. 198(1), 51-61.
2. advanced pharmacetics: physicochemical principle . cherng-ju Kim.publisher,CRC press.ISBN:0849317290.
3. ansels pharmaceutical dosage form and drug delivery system.loyd V.allen Howard C.Ansel Nicholas G.povich.puplisher:Lippincott William &wilkin.8 th edition.ISBN:0781746124.
4. physical pharmacy , Alfred martin ,ph.d. .
This document describes the formulation and evaluation of oral disintegrating tablets of sumatriptan succinate using superdisintegrants. Sumatriptan succinate tablets were prepared using different concentrations of Croscarmellose sodium and treated agar as superdisintegrants. The tablets were evaluated for various physical properties and drug release. Treated agar at 7.5% concentration showed the fastest disintegration time and wetting time compared to other formulations. The results indicate that treated agar provided better superdisintegrant properties than Croscarmellose sodium for formulating oral disintegrating tablets of sumatriptan succinate.
Troubleshooting to Freeze drying fiber formation problemParth Shah
This document summarizes research on the anomalous behavior of mannitol during freeze drying. Mannitol exists in three polymorphic forms (α, β, δ) that have different solubilities and stabilities. The β form has low solubility and is crystalline in nature. Rapid transformation to the stable β form during freeze drying can result in a hazy or turbid solution. Process variables like freezing and annealing rates can affect the resulting polymorph. Approaches to prevent this issue include using a solvent mixture to promote the amorphous δ form, or combining mannitol with other excipients like trehalose that improve stability. Analytical tools like XRD and SEM were used to characterize the polymorphic forms.
Polymers are commonly used to coat pharmaceutical tablets and dosage forms. There are various types of coatings including conventional and enteric coatings. Conventional coatings can improve aesthetics, mask tastes, and modify drug release. Enteric coatings only dissolve in the intestines above pH 5.5-7 to protect acid-sensitive drugs. Common polymers for coatings include cellulose derivatives, acrylates, and polyvinyl derivatives. New techniques like hot melt extrusion can be used to produce enteric coatings. Coatings can provide benefits like targeted drug release and protection of actives or gastric mucosa.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
The document provides an overview of mouth dissolving tablets (MDTs), including definitions, significance, requirements, formulation methodologies, patented technologies, and evaluation. MDTs are also called orally disintegrating tablets that dissolve rapidly in the mouth without water within a few seconds. They provide advantages over traditional tablets like ease of administration for those who have difficulty swallowing. Common formulation methods include freeze drying, molding, spray drying, mass extrusion, and compaction. Patented technologies like OraSolv use effervescent agents that release gas upon contact with water to aid rapid disintegration.
CO–PROCESSED EXCIPIENTS FOR TABLETS.pdfYamini Shah
Purpose of the present review is to provide an in depth knowledge on recent developments in excipients preparation, technology and approaches involved in their formation and development. Excipients play an important role in dosage form development. In conventional formulation of dosage forms, each excipient is used to provide its required function/performance. Presently, excipient manufacturers have focused their attention on producing a multifunctional excipients with improvement in their performance and quality of dosage form. Manipulation in the functionality of excipient is provided by the co-processing of two or more existing excipients.
Matrix structure selection in the microparticles of essential oil oregano pro...Joyce
This document summarizes a study that evaluated different matrix structures for microencapsulating oregano essential oil using spray drying. The researchers used a simplex centroid experimental design to test combinations of Arabic gum, modified starch, and maltodextrin. They analyzed properties like encapsulation efficiency, oil retention, moisture content, and carvacrol concentration. The best results were obtained using 100% Arabic gum, which achieved 93% encapsulation efficiency, and a combination of 74.5% Arabic gum, 12.7% modified starch, and 12.7% maltodextrin, which achieved 77.39% oil retention. Carvacrol concentration was highest (57.8%) using 62.5% Arabic gum and 37
Matrix structure selection in the microparticles of essential oil oregano pro...Joyce
This document summarizes a study that evaluated different matrix structures for microencapsulating oregano essential oil using spray drying. The researchers used a simplex centroid experimental design to test combinations of Arabic gum, modified starch, and maltodextrin. They analyzed properties like encapsulation efficiency, oil retention, moisture content, and carvacrol concentration. The best results were obtained using 100% Arabic gum, which achieved 93% encapsulation efficiency, and a combination of 74.5% Arabic gum, 12.7% modified starch, and 12.7% maltodextrin, which achieved 77.39% oil retention. Carvacrol concentration was highest at 57.8% when using 62.5% Arabic gum and
This document describes research into using encapsulated mixed enzymes from Bacillus subtilis and Burkholderia cepacia to produce biodiesel from waste cooking oil via interesterification. Response surface methodology and a central composite experimental design were used to optimize reaction parameters including enzyme loading, oil to methyl acetate ratio, temperature, and reaction time. The optimal conditions found were 2 g enzyme loading, a 1:12 oil to methyl acetate ratio, 60 hours reaction time, and 35°C temperature, yielding 93.61% biodiesel. Immobilizing the enzymes allowed them to be reused for 20 cycles without loss of activity. Producing biodiesel from waste cooking oil via this enzymatic method provides an ecofriendly and cost
Similar to Metoformin HCL - Know how technology (20)
1. Author’s Accepted Manuscript
The importance of binder moisture content in
Metformin HCL high-dose formulations prepared
by moist aqueous granulation (MAG)
Hiroshi Takasaki, Etsuo Yonemochi, Masanori Ito,
Koichi Wada, Katsuhide Terada
PII: S2211-2863(15)00003-2
DOI: http://dx.doi.org/10.1016/j.rinphs.2015.09.001
Reference: RINPHS37
To appear in: Results in Pharma Sciences
Received date: 9 May 2015
Revised date: 28 August 2015
Accepted date: 14 September 2015
Cite this article as: Hiroshi Takasaki, Etsuo Yonemochi, Masanori Ito, Koichi
Wada and Katsuhide Terada, The importance of binder moisture content in
Metformin HCL high-dose formulations prepared by moist aqueous granulation
( M A G ) , Results in Pharma Sciences,
http://dx.doi.org/10.1016/j.rinphs.2015.09.001
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com/locate/rinphs
2. 1
The importance of binder moisture content in Metformin
HCL high-dose formulations prepared by moist aqueous
granulation (MAG)
Hiroshi Takasakia
, Etsuo Yonemochib
, Masanori Itoa
, Koichi Wadaa
, Katsuhide
Teradac
a
Nippon Boehringer Ingelheim Co., Ltd. 6-7-5 Minatojima Chuou-ku Kobe Hyogo 650-0047, Japan
b
Institute of Medicinal Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, 142-8501 Tokyo,
Japan
c
Faculty of Pharmaceutical Science, Toho University,2-2-1 Miyama Funabashi Chiba 274-8510, Japan
Abstract
The aim of this study was to evaluate binders to improve the flowability of granulates
and compactibility of Metformin HCL (Met) using the moist aqueous granulation
(MAG) process. The effect of the binder moisture content on granulate and tablet
quality was also evaluated. Vinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64
fine: VA64), polyvidone (Povidone K12: PVP), hydroxypropyl cellulose (HPC SSL SF:
HPC) and hydroxypropyl methylcellulose (Methocel E5 LV: HPMC) were evaluated as
binders. These granulates, except for HPMC, had a lower yield pressure than Met active
pharmaceutical ingredient (API). HPMC Met was not sufficiently granulated with low
water volume. No problems were observed with the VA64 Met granulates during the
tableting process. However, HPC Met granulates had a bowl-forming tendency, and
PVP Met granulates had the tendency to stick during the tableting process. These
bowl-forming and sticking tendencies may have been due to the low moisture
absorbency of HPC and the high volume of bound water of PVP, respectively. VA64
Met granulates had the highest ambient moisture content (bulk water, bound water) and
moisture absorbency. It was concluded that the type of binder used for the Met MAG
process has an impact on granulate flow and compactibility, as well as moisture
absorbency and maintenance of moisture balance.
3. 2
Keywords
Metformin HCL, Moist aqueous granulation, Binder, Moisture absorbency
1. Introduction
The selection of excipients is very important for the formulation development of solid
oral dosage forms. The fundamental function of excipients is to act as a diluent, or filler.
Further functions include the controlled release of the active pharmaceutical ingredient
(API), permeability enhancement to aid absorption of the API, stabilization of the API,
and improved manufacturability of the formulation (Lee, 2002). Many types of
excipients are available to improve powder flow, compactibility, and disintegration
(Tousey, 2002).
The selection of excipient is especially critical for high-dose formulations, due to the
need to minimize the volume of excipient utilized to keep the tablet size acceptable for
swallowing despite the increased drug load. There have been previous reports
evaluating the properties and considerations necessary for high-dose formulations.
Cantor et al. evaluated the physicochemical properties of high drug load formulations
manufactured using conventional wet or foam granulation process. Acetaminophen
(APAP), Metformin HCL (Met), and Aspirin were used as model APIs (80% w/w).
According to their results, foam granulation improved the plasticity of granulates
containing a brittle drug such as APAP. On the other hand, foam granulation did not
enhance the plasticity for viscoelastic material such as Met (Cantor et al., 2009).
Barot et al. described the feasibility of directly compressing Met by the spray-drying
process in the presence of polymer. Their results showed that the use of polyvidone
(PVP) during the spray-drying process resulted in better properties of the Met
formulation (Barot et al., 2010).
Uroš et al. evaluated the hydroxypropyl methylcellulose (HPMC) and hydroxypropyl
cellulose (HPC) polymer threshold amount for robust drug release from matrix tablets
containing high dose levetiracetam (BCS class Ι compounds). The evaluation of the
amount of HPC and HPMC achieved a good correlation of in vitro results and in vivo
results (Klančar et al., 2015).
Tan et al. evaluated the combination of hydrophilic binder and hydrophobic binder on
the dissolution profile of the verapamil high dose tablet produced by direct-molding
melt granulation process with the twin-screw extruder design of experiment (DOE)
approach. The hydrophilic binder had a significant impact on the release profile of
4. 3
verapamil (Tan et al., 2014).
Lakshman et al. evaluated the use of the melt granulation (MG) process to enhance the
tableting properties of poorly compactable high-dose drugs. Using Met as the model
drug (88.2% w/w) and HPC as the polymeric excipient, the formulation was granulated
by twin screw extruder and resulted in high compactibility and low friability (Lakshman
et al., 2010).
Moisture-activated dry granulation (MADG) may be an interesting alternative which
combines the benefits of high shear granulation while avoiding the issues of drying as
found in the processes described above. This process was initially described by Ullah et
al. in 1987 (Ullah et al., 1987) and may be performed within a conventional high shear
granulator, with pre-blending of all components intended for granulation and then a
final blending prior to compression with further functional excipients, such as
disintegrants or lubricants.
The MADG process can be divided into two different stages: the agglomeration stage
and the moisture absorption stage (Ullah et al., 2009b, 2010). The API, water-soluble
fillers, and binders are initially pre-mixed in the granulator followed by activation of the
binder by a small volume of water to form granulates. MADG typically requires a
significantly smaller volume of granulation liquid compared to the conventional HSG
process (1-4% (m/m)) (Ullah et al., 2009b). During the absorption stage, moisture
within the granulates is reduced and distributed throughout the whole blend by
subsequent addition of a water insoluble filler as an absorbent component.
MADG has been previously evaluated by some researchers (Chen et al., 1990; Railkar
and Schwartz, 2000, 2001). Ullah et al. described the manufacturability of a high-dose
drug formulation (62.5%) using MADG (Ullah et al., 2009a). Tablets produced with the
MADG process showed higher tensile strength and faster disintegration compared to
tablets produced with high shear granulation (Takasaki et al., 2013).
Met is an oral antihyperglycemic drug used for treatment of non-insulin-dependent
diabetes mellitus (Brittain, 1998). Commercial Met products consist of 500mg, 850mg,
and 1000mg doses. The drug load of Met IR tablets must be greater than 90% w/w to
ease swallowing. If MADG is used for Met 90% w/w formulation, the moisture
absorbents must be omitted or reduced to retain the proper tablet size.
Lakshman et al. utilized the moist aqueous granulation (MAG) process for Met
formulation development (Lakshman et al., 2010). This manufacturing process is
similar to MADG; however, MAG employs only the agglomeration stage without the
5. 4
moisture absorbent stage. In their study, the components of their formulation consisted
of API, binder, and magnesium stearate. Met and binder were activated with a small
volume of water, and the agglomerates were then blended with magnesium stearate.
Their results showed that the Met granulates prepared by MAG showed poor flow
during the tableting process due to extreme moisture sensitivity.
MAG is a simple process compared to other granulation processes. In general wet
granulation, moisture control is necessary in the drying process. Air flow, temperature
and other manufacturing conditions should be evaluated to determine the critical
process parameter (CPP) of the drying process. And because MAG omits the drying
process, it is beneficial for drugs which are less heat-resistant. Met is shown to be
highly susceptible to moisture and will change its flow and form a large agglomerate
depending on the moisture content. Therefore, the moisture content of Met granules
should be controlled during the wet granulation and drying process. On the other hand,
because MAG requires a significantly small volume of granulation liquid, the drying
process is omitted. Moisture content can be easily controlled by adjusting the amount of
liquid added, which could reduce CPP. This manufacturing method may be beneficial to
the Met granulation process.
The binder is the most important excipient for wet granulation (Bouwman et al., 2005;
Joneja et al., 1999; Schæfer et al., 2004). However, little is known about the choice of
binder most appropriate for high-dose Met formulation using MAG. The aim of this
study was to evaluate the binder types for improved granulate flow and compactibility
of Met using MAG without moisture absorbents, as well as the effect of moisture
content on granulate and tablet quality.
2. Materials and methods
2-1. MGT batches
Met (Weifa) was passed through a 1.0 mm screen and then mixed with one of the
following binders: vinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64 fine:
VA64, BASF), polyvidone (Povidone K12: PVP, BASF), hydroxypropyl cellulose (HPC
SSL SF: HPC, Nippon Soda), and hydroxypropyl methylcellulose (Methocel E5 LV:
HPMC, Dow Chemical). Batch scales of 250 g were processed in a high shear
granulator (Diosna P1/6, Diosna) equipped with a 1L granulation bowl. Processing
parameters were kept constant throughout the agglomeration (1 min) and massing (3
min) stage: impeller 500 rpm, chopper 1200 rpm. The mixtures were granulated by
6. 5
spraying 1.0 %, 1.5 %, or 2.0 % (m/m) water for about 10-15 s (nozzle diameter 0.3 mm,
atomizing air pressure 2.5 bar) into the granulation bowl. The pre-sieved lubricant
magnesium stearate (vegetable magnesium stearate, Faci) was blended directly into the
granulator for 0.5 min at a reduced impeller speed of 250 rpm. The final blends were
sieved by a conical sieving machine (1.0 mm rasp sieve, Quadro Comil U5, Powrex).
The final blends were compressed to flat-faced tablets with a diameter of 8 mm and
mass of 200 mg on an eccentric press (FlexiTab, Manesty) at different compression
stages of 2.5 kN, 5 kN, 7.5 kN, 10.0 kN, and 15.0 kN.
2-2. Particle size distribution
Particle size distribution of the final blends was measured by sieve analysis (Robot
Shifter RPS-95, Seishin) employing the following screens: 355 m, 250 m, 180 m,
125 m, 90 m, 75 m, and 63 m for a sifting time of 5 min on vibration level 4 and
pulse interval of 1 s.
2-3. Bulk and tapped densities
Bulk and tapped densities of the final blends were determined in a 100 mL sample cup
on a powder property measurement system (Powder Tester PT-R, Hosokawa micron) by
applying 180 taps. The Hausner ratio as a surrogate for flowability was calculated as the
ratio of tapped and bulk densities: ( tapped / bulk). The flowability was classified
according to USP from excellent (1.00-1.11), good (1.12-1.18), fair (1.19-1.25) to
passable (1.26-1.34).
2-4. Tablet porosity
Tablet porosity () was calculated by employing the equation = 1- (m/ true* V),
where m and V are the mass and volume of the tablets, respectively. True density (
true) was measured by using a mercury penetration porosimeter (Accupyc II 1340,
Micromeritics).
2-5. Compaction analysis
The Heckel equation is widely used for obtaining information from the compression
properties of pharmaceutical powders (Çelik, 1992). The final blends were compressed
to flat-faced tablets with a diameter of 11 mm and a mass of about 300 mg on an
eccentric press (FlexiTab, Manesty) at a compression force of 25 MPa. The reduction of
volume and density by the applied compression force can be calculated using the
Heckel equation (Sunil,1999). The compactibility of the final Met blends was calculated
7. 6
using the Heckel equation (equation 1) Ln (1 / 1-D) = K*Pa + A, where D is the relative
density, Pa is the applied pressure, K is the Heckel coefficient, and A is the Heckel
intercept. K and A are the regression coefficients of the linear portion of the Heckel
profile. Yield pressure (Py) was expressed as Py = 1 / K. Materials with high
compactability showed higher slope than that of brittle fracture, implying the former has
a lower yield pressure (Yihong,2009). The elastic recovery was calculated based on the
compaction profile during the decompression phase of compaction (Sunil,1999) using
the FlexiTab software.
2-6. Tablet hardness and thickness
Crushing strength of the tablets and tablet height were measured using a tablet
hardness tester (TBH425, ERWEKA). Tensile strength was calculated as 2 F/ (* D*
T): where F is the hardness, and D and T are the diameter and thickness of the tablets.
2-7. Near infrared spectroscopy (NIRS)
NIR spectra of Met granulates were measured between 1100 and 2500 nm at 2 min
increments using a Foss NIR system Model 6500 equipped with a Rapid-ContentTM
analyzer. NIR data analysis was calculated using Vision®
software (Vision 2.51, Foss
NIR system).
2-8. Water vapor sorption isotherms
The Dynamic Vapor Sorption Intrinsic (DVS INTRINSIC) system was used for the
determination of water vapor adsorption and desorption isotherms at 25.0 ºC. Water
vapor was introduced to the sample at increments of 0 % RH to 95 % RH.
2-9. Thermogravimetry (TG)
The absorbed water from the Met granulates was measured using the Rigaku Dynamic
TG-DTA system (Thermo plus TG8120). Thermal analyzers have a controlled rate
thermal analysis mode that can be used to automatically raise the temperature for
quasi-isothermal thermogravimetry. This mode makes it possible to isolate the various
reactions that occur at similar temperature. The constant reaction-rate control mode was
used for evaluating detailed evaporation behavior (Ohtake et al., 2006). The weight of
samples was approximately 15mg. The samples were loaded into aluminum pans and
heated from 20 ºC to 130 ºC in a nitrogen atmosphere. The initial heating rate was
2o
C/min, and the water evaporation rate of 0.001 %/sec was maintained at a constant
level.
8. 7
2-10 Scraping force
Scraping force is the force required to scrape the tablet off the punch face. The force is
measured by using the shear stress of the scrapper. Scrapping force is related to the
sticking tendency during the tableting process.
The final blends were compressed to flat-faced tablets with a diameter of 8 mm and a
mass of 200 mg on an eccentric press (Korsch EK0, Korsch) at 5 kN. The scrapping
force of this evaluation was defined as the shear stress after producing 30 tablets.
3. Results and discussion
3-1 MAG process and granulate characteristics
Table 1 shows the formulations in this study. The granulates produced with VA64 and
HPC and 2.0 % water failed due to bowl-forming during the MAG process. The other
MAG formulations performed better, with no wall adhesions or formation of big lumps
observed.
Granulate characteristics are shown in Table 2. The mean particle size of Met
granulates produced with VA64 (added water 1.0 %, 75 m; 1.5 %, 164 m) and HPC
(added water 1.0 %, 111 m; 1.5 %, 152 m) increased with increasing volume of
added water. The PVP Met granulates had similar sizes (136 m) when made with either
1.5% or 2.0% added water, which might not have an impact on the granule
enlargements. The volume of water for granulation may have been too low for the
HPMC Met granulates, which may be why the particles were smaller than other
formulations.
The physical state of binders during the granulation process has a significant impact on
the wet granulation process and granule, tablet properties. Li et al. evaluated the
physical state of a binder on wet granulation and granule properties using the binary
model system. PVP K12 needed a small amount of water to change from glassy to the
rubbery/solution state for granule enlargement. On the other hand, HPMC required
longer granulation time and more water to reach the solution state (Li et al., 2011). PVP
might reach the rubbery/solution state faster compared to the other binders, which
caused the granule enlargement with a small amount of water (added water 1.0 %, 111
m). HPMC might not change from glassy to the rubbery/solution state with a small
amount of added water (1.0 %, 1.5 %, 2.0 %).
The Hausner ratio of all Met granulates was acceptable (1.13-1.33).
9. 8
3-2 Compaction analysis
Figure 1 shows the Heckel plots of Met API and the Met granulates produced with the
VA64 as examples, and Table 3 shows the summary of the Heckel analysis. The yield
pressure and elastic recovery was calculated by the Heckel plots profile (See section
2-5). For this analysis, the volume of added water was 1.5%. Intact Met API was also
evaluated for the comparison. Oleic acid was coated thinly over the punches for
prevention of sticking.
Material with a high-yield pressure results in brittle-fracturing or fragmentation. On
the other hand, material with a low-yield pressure results in plastic deformation
(Nokhodchi, 2005). Met is a well-known viscoelastic drug (Cantor et al., 2009), and the
yield pressure of Met API was 227 MPa. The addition of binders resulted in a lower
yield pressure than Met API. The granulation process might have improved the
compactability of Met. The yield pressures of Met granulates produced with VA64 (114
MPa), PVP (167 MPa), and HPC (157 MPa) were significantly lower (VA64 49.7 %,
PVP 26.4 %, HPC 30.8 %) than Met API. However, the yield pressure of HPMC Met
granulates (220 MPa; 96.8 %) was very similar to that of Met API. Granulate
characteristics are shown in Table 2. HPMC Met granulates had a small particle size and
high Hausner ratio compared to other granulates, indicating that HPMC Met granulates
are unable to be properly granulated when the volume of added water is low. For the
MADG process, binders should be easily wettable and become tacky with a small
volume of water for the agglomeration stage (Ullah et al., 2009b). HPMC was unable to
be activated with a small volume of water. Therefore, the yield pressure of the HPMC
Met granulate was the same as that of Met API. On the other hand, Met granulates
produced with other binders were able to be activated with a small volume of water,
indicating that the yield pressure when using these binders was lower than those of Met
API and HPMC Met granulates.
The elastic recovery of all granulates was very similar to Met API. HPMC Met
granules showed higher elastic recovery (0.87 %) than other Met granules. Nokhodchi
et al. evaluated the effect of moisture content on HPMC K4M compaction properties
(Nokhodchi, 2005). The eastic recover of HPMC K4M was changed from 17 % to 6 % ,
as the relative humidity increased from 23 % to 75 %. But the elastic recovery
difference of this study was below 1.0 %. This difference might not have a big impact
on the tablet properties.The binder type did not have any impact on elastic recovery.
10. 9
3-3 Tensile strength (Met granulates produced with VA64, PVP and HPC)
The effect that binder type may have on the tensile strength of the tablets was
investigated using VA64, PVP, and HPC. Figure 2 shows the tensile strength of the
tablets as a function of compression force. No problems were observed when tableting
VA64 Met granulates, but the tablets showed poor tensile strength when the volume of
added water was 1.0 % (0.41 MPa at 10 kN). However, when the volume of added
water was increased from 1.0 % to 1.5%, VA64 Met granulates achieved adequate
tensile strength (1.59MPa at 10kN). As VA 64 did not reach the rubbery/solution state
with a small amount of added water (1.0 %), the VA 64 Met granule may have
inadequate granulation and show a low gain in hardness.
The tableting of PVP Met granulates showed high sticking tendency when the volume
of added water was 1.5 % or 2.0 %. In particular, continuous tableting was difficult due
to sticking when the volume of added water was 2.0%, resulting in the discontinuation
of the tableting process. The tensile strength did not increase when the volume of added
water was increased from 1.0 % (1.13 MPa at 10 kN) to 1.5 % (1.03 MPa at 10 kN).
HPC Met granulates showed poor granulate flow due to a bowl-forming tendency
during the tableting process. Therefore, a vibrator was used for enhancing granulate
flow during the tableting process of HPC Met granulates. A previous report has shown
similar results; using the MAG process, the compaction of HPC Met required low
humidity to achieve adequate granulate flow (Lakshman et al., 2010). Therefore, they
concluded that use of the MAG process was difficult due to the moisture sensitivity of
HPC Met granulates.
3-4 Evaluation of water vapor sorption isotherms (Met granulates produced with VA64,
PVP, and HPC)
After tableting, Met granulates produced with various binders exhibited different
behaviors. No problems were observed for the VA64 Met granulates during the tableting
process. However, HPC Met granulates had a bowl-forming tendency, and PVP Met
granulates had the tendency to stick. Because the binder type was the only difference
between the formulations, these may have had an impact on the moisture content of the
Met granulates.
Figure 3 shows the water vapor sorption isotherms of Met API and Met granulates
produced with VA64, PVP, and HPC. Met API is able to absorb only a very small
amount of moisture (0.011 %: at 50 % RH, 0.097 %: at 90 % RH). Solubility of Met
11. 10
API is over 100 mg/ml in water (Cheng et al., 2004). When the added water amount was
1.5 % during the MAG process, the Met API may be crystalline (over 99 %) during the
MAG process based on the calculation of the added water amount in MAG and MET
API solubility. On the other hand, Met granulates produced with the various binders
showed much higher moisture absorbency than Met API. Therefore, binders may have a
significant impact on the moisture uptake of Met granulates.
HPC Met granulates absorbed 0.29 % moisture at 50 % RH. On the other hand, VA64
and PVP Met granulates absorbed 0.49 % and 0.80 % moisture, respectively, at 50 %
RH. VA64 and PVP Met granulates absorbed 1.7- 2.8 times more moisture than HPC
Met granulates. HPC Met granulates had the lowest moisture absorbency; therefore,
HPC may have a limited capacity of water uptake compared to VA64 and PVP. The
binder may have an impact on the moisture absorbency of Met granulates. Addition of
1.0 % or 1.5 % of water was too high for HPC Met granulates, and a tendency to block
was observed during the tableting process.
3-5 Evaluation of the molecular state of water by NIRS (Met granulates produced with
VA64 and PVP)
The NIR band around 1900 nm -1950 nm shows the molecular state of water, with the
water band split into peaks of 1900 nm and 1930 nm, reflecting the bulk water and
bound water volumes, respectively. The peak position reflects the moisture mobility of
absorbed water (Ohtake et al., 2006).
A difference in the tableting properties was observed between VA64 and PVP Met
granulates. Therefore, the moisture distribution (bound water and bulk water) of VA64
and PVP Met granulates was evaluated by NIRS. Figure 4 shows second derivative
NIRS spectra, with the peak of the VA64 Met granulates wider compared to the peak of
the PVP Met granulates. In particular, the peak position of the VA64 Met granulates
around 1930 nm reflecting bound water was wider than the peak position of the PVP
Met granulates. Additionally, the peak intensity of the PVP Met granulates around 1930
nm was strong. Therefore, the distributions of bound and bulk water were completely
different between the VA64 and PVP Met granulates.
3-6 Evaluation of the molecular states of water by TG (Met granulates produced with
VA64 and PVP)
Many researchers have investigated the effect of moisture content on tablet
compactibility. It was found that for paracetamol powder, the mean yield pressure
12. 11
decreased with increasing moisture content (Garr and Rubinstein, 1992). However,
tensile strength reached a maximum, and then declined, when moisture content
approximately doubled (Malametaris et al., 1991). Conflicting results on tensile strength
may be due to the moisture state of the powders (Nokhodchi, 2005). Based on these
results, by increasing or decreasing the amount of moisture, tensile strength may be
increased or decreased.
The NIRS results showed that the moisture contents of the VA64 and PVP Met
granulates were different; however, these results were unable to clarify the detailed
distribution of moisture in the Met granulates. Ohtake et al. reported that NIR spectral
analysis and TG measurement for pharmaceutical additives enabled us the evaluation of
molecular states of water existing in the samples. McCrystal and Ford et al. evaluated
water distribution within the range of polymer by using DSC. Water molecules of the
polymer could be classified into 2 groups: bound water and bulk water (McCrystal et al.,
1999). The molecules of bound water showed a lower wavenumber region due to
interaction with the polar group of the polymer by FTIR spectroscopy. The strongly
hydrogen-bonded water molecules moved to free water with increasing water content
due to the saturation of the strong binding site of polymer (Szakonyi and Zelkó, 2012).
The binding energy of free water seems to be lower than the energy of bound water.
TG was used to evaluate the distribution of moisture content in this study, which was
divided into two states: bulk water and bound water. The bulk water was calculated by
measuring the water loss around room temperature. The bound water was calculated by
measuring the water loss above room temperature. Figure 5 shows the water states for
the VA64 and PVP Met granulates. The bulk water content in the VA64 Met granulates
was 0.35 % (volume of added water, 1.0 %), and 0.34 % (volume of added water,
1.5 %), approximately the same despite an increase in added water from 1.0 % to 1.5 %.
On the other hand, bound water content in the VA64 Met granulates increased from
0.11 % to 0.21 % with an increasing volume of added water. Tablet tensile strength also
increased with increasing volume of added water, suggesting that the volume of bound
water may have an impact on tensile strength.
PVP Met granulates had 3.5 times (volume of added water, 1.0 %) and 1.9 times
(volume of added water, 1.5 %) higher bound water content compared to the VA64 Met
granulates. PVP Met granulates had 1.7 times (volume of added water 1.0 %) and 2.3
times (volume of added water 1.5 %) higher bulk water content compared to VA64 Met
granulates.
These results show that Met granulates produced with VA64 and PVP have very
different volumes of bound and bulk water.
13. 12
3-7 Impact of the state of water on tablet sticking (Met granulates produced with VA64
and PVP)
Sticking refers to granulate adhesion to the punch and die surfaces, with powder
moisture having a significant impact on sticking. Tablet sticking is estimated by
measuring the scraping force (Danjo et al., 1997; Wang et al., 2004), which is the force
required to scrape the tablet off the punch face; scraping force increases with increasing
sticking (Morita et al., 2002).
TG-DTA showed that the VA64 and PVP Met granulates had different moisture
contents. However, the relationship between moisture content and sticking was not clear,
and the association between the volume of bound water, bulk water, and scraping force
was evaluated.
Figure 6 shows the association between the volume of bound water, bulk water, and
scraping force. A powder in dry form exhibits cohesiveness due to electrostatic charge,
and may become more free-flowing as humidity is increased. If humidity is further
increased, liquid bridge formation may result in a return to cohesive behavior (Rhodes,
2008). Therefore, if the moisture content is increased beyond the threshold, the scraping
force significantly increases. Measurement of total moisture content may not be a good
approach for understanding the effects of water. Therefore, the impact of bulk and
bound water on the scrapping force was evaluated. The threshold of the bound water
content was about 0.4 %. On the other hand, the threshold of the bulk water content was
higher, at 0.6 % - 0.7 %. These results show that a higher content of bound water may
be the cause of sticking tendencies.
PVP Met granulates had a higher content of bound water compared to the VA64 Met
granulates. Therefore, the sticking tendency of PVP Met granulates may be due to the
higher content of bound water.
It has been shown that moisture content has a significant impact on tablet properties
(Nokhodchi, 2005). The VA64 Met granulates’ bound water content of below 0.4 % and
moisture absorbency (3.0 % at 90 %RH, 11 % at 95 %RH) might have a positive impact
on the tablet properties.
4. Conclusion
Using MAG, we have prepared Met granulates using VA64, PVP, HPC, and HPMC as
binders. The compactibility of the Met final blends was evaluated using the Heckel
equation. Met API was also evaluated for comparison. These granulates, except for
HPMC (Yield pressure 220 MPa), have a lower yield pressure compared to Met API
14. 13
(Yield pressure 227 MPa). HPMC Met granulates have a higher Hausner ratio (1.33,
volume of added water 2.0 %) compared to Met granulates produced with other binders.
The granulation process was able to improve granule compactability and flowability.
HPMC Met granulates are unable to be sufficiently granulated at low water volumes
(volume of added water 2.0 %). During the tableting process, VA64 Met granulates
exhibited no problems, but HPC Met granulates exhibited a bowl-forming tendency, and
PVP Met granulates had a tendency to stick during the tableting process. VA64 and PVP
Met granulates absorbed 1.7- 2.8 times more moisture than HPC Met granulates at 50 %
RH. HPC Met granulates had the lowest moisture absorbency (0.29 % at 50 %RH);
HPC may have a limited capacity for water uptake compared to VA64 and PVP. The
distribution of moisture content (bulk water, bound water) of PVP and VA64 Met
granulates was evaluated by TG. PVP Met granulates had higher bound water and bulk
water contents compared to the VA64 Met granulates. Tablet sticking was estimated by
measuring the scraping force, and the association between the bound water and bulk
water content with the scraping force was evaluated. The threshold of bound water
(0.4 %) was lower than that of bulk water (0.6 %-0.7 %). The high content of bound
water may be the cause of the sticking tendency of the PVP Met granulates. The VA64
Met granulates’ bound water content of below 0.4 % for preventing sticking tendencies
and moisture absorbency (3.0 % at 90 %RH, 11 % at 95 %RH) might have a positive
impact on the Met tablet properties.
Acknowledgement
This project was supported in part by a Grant-in-Aid for Scientific Research (C), Japan
Society for the Promotion of Science (KAKENHI Grant no. 26460048), and the Science
Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private
Schools of Japan.
References
Barot, B.S., Parejiya, P.B., Patel, T.M., Parikh, R.K., Gohel, M.C., 2010. Development
of directly compressible metformin hydrochloride by the spray-drying process. Acta
pharmaceutica 60, 165-175.
Bouwman, A., Henstra, M., Westerman, D., Chung, J., Zhang, Z., Ingram, A., Seville, J.,
Frijlink, H., 2005. The effect of the volume of binder liquid on the granulation
mechanisms and structure of microcrystalline cellulose granulates prepared by high
shear granulation. Int J Pharm 290, 129-136.
15. 14
Brittain, H.G., 1998. Analytical profiles of drug substances and excipients. Academic
Press.
Cheng, C.-L., Lawrence, X.Y., Lee, H.-L., Yang, C.-Y., Lue, C.-S., Chou, C.-H., 2004.
Biowaiver extension potential to BCS Class III high solubility-low permeability drugs:
bridging evidence for metformin immediate-release tablet. European journal of
pharmaceutical sciences 22, 297-304.
Cantor, S.L., Kothari, S., Koo, O.M.Y., 2009. Evaluation of the physical and mechanical
properties of high drug load formulations: Wet granulation vs. novel foam granulation.
Powder technology 195, 15-24.
Çelik, M., 1992. Overview of compaction data analysis processs. Drug Development
and Industrial Pharmacy 18, 767-810.
Chen, C.M., Alli, D., Igga, M.R., Czeisler, J.L., 1990. Comparison of
Moisture-Activated Dry Granulation Profess with Conventional Granulation Methods
for Sematilide Hydrochloride Tablets. Drug Development and Industrial Pharmacy 16,
379-394.
Danjo, K., Kojima, S., Chen, C.Y., Sunada, H., Otsuka, A., 1997. Effect of water
content on sticking during compression. Chemical and pharmaceutical bulletin 45,
706-709.
Garr, J., Rubinstein, M., 1992. The influence of moisture content on the consolidation
and compaction properties of paracetamol. Int J Pharm 81, 187-192.
Joneja, S.K., Harcum, W.W., Skinner, G.W., Barnum, P.E., Guo, J.H., 1999.
Investigating the fundamental effects of binders on pharmaceutical tablet performance.
Drug Dev Ind Pharm 25, 1129-1135.
Klančar, U., Baumgartner, S., Legen, I., Smrdel, P., Kampuš, N.J., Krajcar, D., Markun,
B., Kočevar, K., 2015. Determining the Polymer Threshold Amount for Achieving
Robust Drug Release from HPMC and HPC Matrix Tablets Containing a High-Dose
BCS Class I Model Drug: In Vitro and In Vivo Studies. AAPS PharmSciTech 16,
398-406.
Lakshman, J.P., Kowalski, J., Vasanthavada, M., Tong, W.Q., Joshi, Y.M., Serajuddin,
A.T., 2010. Application of melt granulation technology to enhance tabletting properties
of poorly compactible high-dose drugs. Journal of pharmaceutical sciences.
Lee, K.M., 2002. Overview of drug product development. Current Protocols in
Pharmacology, 7.3. 1-7.3. 10.
Li, J., Tao, L., Dali, M., Buckley, D., Gao, J., Hubert, M., 2011. The effect of the
physical states of binders on high-shear wet granulation and granule properties: a
mechanistic approach towards understanding high-shear wet granulation process. Part I.
16. 15
Physical characterization of binders. Journal of pharmaceutical sciences 100, 164-173.
Malametaris, S., P.Goidas, A.Dimitriou, 1991. Moisture sorption and tensile strength of
some tableted direct compression excipients. Int J Pharm 68, 51-60.
McCrystal, C.B., Ford, J.L., Rajabi‐Siahboomi, A.R., 1999. Water distribution studies
within cellulose ethers using differential scanning calorimetry. 2. Effect of polymer
substitution type and drug addition. Journal of pharmaceutical sciences 88, 797-801.
Morita, Y., Tsushima, Y., Yasui, M., Termoz, R., Ajioka, J., Takayama, K., 2002.
Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method
utilizing a CCD camera. Chemical and pharmaceutical bulletin 50, 1181-1186.
Nokhodchi, A., 2005. Effect of moisture on compaction and compression. Pharm. Tech,
46-62.
Ohtake, N., Yonemochi, E., Terada, K., 2006. Chratcerization of the moleculer state of
water present in pharmaceutical additives by NIR spectroscopy. Asian journal of
pharmaceutical science 1, 43-46.
Railkar, A.M., Schwartz, J.B., 2000. Evaluation and comparison of a moist granulation
process to conventional methods. Drug Development and Industrial Pharmacy 26,
885-889.
Railkar, A.M., Schwartz, J.B., 2001. Use of a moist granulation process (MGT) to
develop controlled-release dosage forms of acetaminophen. Drug Development and
Industrial Pharmacy 27, 337-343.
Rhodes, M., 2008. Introduction of Particle technology. 340.
Schæfer, T., Johnsen, D., Johansen, A., 2004. Effects of powder particle size and binder
viscosity on intergranular and intragranular particle size heterogeneity during high shear
granulation. European journal of pharmaceutical sciences 21, 525-531.
Sunil, J., 1999. Mechanical prpperties of powders for compaction and tabletting: an
overview. PSTT 2, 20-31
Szakonyi, G., Zelkó, R., 2012. The effect of water on the solid state characteristics of
pharmaceutical excipients: Molecular mechanisms, measurement techniques, and
quality aspects of final dosage form. International journal of pharmaceutical
investigation 2, 18.
Takasaki, H., Yonemochi, E., Messerschmid, R., Ito, M., Wada, K., Terada, K., 2013.
Importance of excipient wettability on tablet characteristics prepared by moisture
activated dry granulation (MADG). International journal of pharmaceutics 456, 58-64.
Tan, D.C.T., Chin, W.W.L., Tan, E.H., Hong, S., Gu, W., Gokhale, R., 2014. Effect of
binders on the release rates of direct molded verapamil tablets using twin-screw
17. 16
extruder in melt granulation. International journal of pharmaceutics 463, 89-97.
Tousey, M.D., 2002. The Granulation Process 101. Pharm Tech, 8-13.
Ullah, I., Corrao, R., Wiley, G., Lipper, R., 1987. Moisture activated dry granulation: A
general process. Pharm. Technol 11, 48-54.
Ullah, I., Wang, J., Chang, S.Y., Guo, H., Kiang, S., Jain, N.B., 2009a.
Moisture-Activated Dry Granulation Part II: The Effects of Formulation Ingredients and
Manufacturing-Process Variables on Granulation Quality Attributes. Pharmaceutical
Technology 33, 42-51.
Ullah, I., Wang, J., Chang, S.Y., Wiley, G.J., Jain, N.B., Kiang, S., 2009b.
Moiture-Activated Dry GranulationI: A Guide to Excipient and Equipment Selection
and Formulation Development. Pharmaceutical Technology 33, 62-70.
Ullah, I., Wang, J., Chang, S.Y., Wiley, G.J., Jain, N.B., Kiang, S., 2010.
FORMULATION-Moisture-Activated Dry Granulation, Part 1-The authors provide
guidance for the selection of excipients and equipment to formulate a moisture-activated
dry-granulation process. Pharmaceutical Technology 33, 62.
Wang, J.J., Guillot, M.A., Bateman, S.D., Morris, K.R., 2004. Modeling of adhesion in
tablet compression. II. Compaction studies using a compaction simulator and an
instrumented tablet press. Journal of pharmaceutical sciences 93, 407-417.
Yihong, Qiu., 2009. Developing solid oral dosage forms.418-419.
18. 17
Figures
Fig. 1. Heckel analysis profile
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
0 50 100 150 200 250
ln1/(1-D)
Pressure (MPa)
API
Met+VA64
0.00
0.50
1.00
1.50
2.00
0 5 10 15 20
Tensilestrength(MPa)
Compression force (kN)
Met + VA64 Amount of added water 1.0%
Met + VA64 Amount of added water 1.5%
Met+VA 64
Met + PVP
0.00
0.50
1.00
1.50
2.00
0 5 10 15 20
Tensilestrength(MPa)
Compression force (kN)
Met + PVP Amount of added water 1.0%
Met + PVP Amount of added water 1.5%
19. 18
Fig. 2. Compression force vs. tensile strength of tablets (Mean n=10, SD)
Fig. 3. Water vapor isotherms of Met granules containing various binders at 25 C° (volume of added
water, 1.5%)
Met + HPC
0.00
0.50
1.00
1.50
2.00
0 5 10 15 20
Tensilestrength(MPa)
Compression force (kN)
Met + HPC Amount of added water 1.0%
Met + HPC Amount of added water 1.5%
0
2
4
6
8
10
12
14
16
0 20 40 60 80 100
Changeinmass(%)
Relative humidity (%)
Met API
Met + VA64
Met + PVP
Met + HPC
20. 19
Fig. 4. Second derivative of the NIR spectra in the region 1850 - 1950nm for Met granules (volume
of added water 1.5%, mean n=3)
Met + VA 64
-0.02
0.0
0.02
0.04
0.06
0.08
0.1
1850 1870 1890 1910 1930 1950
SecondderivativeoftheNIRspectra
Wavelength (nm)
Met + VA64
Met + PVP
0.11
0.21
0.35
0.34
0.00
0.50
1.00
1.50
1.0 1.5
Amountofwater(%)
Amount of added water (%)
Bulk water
Bound water
21. 20
Fig. 5. Water states for Met granules (mean n=3)
Met + PVP
0.38 0.39
0.58
0.78
0.00
0.50
1.00
1.50
1.0 1.5
Amountofwater(%)
Amount of added water (%)
Bulk water
Bound water
0
5
10
15
20
25
0.0 0.2 0.4 0.6 0.8 1.0
Scrapingforce(N)
Amount of bound water (%)
22. 21
Fig. 6. Content of bound and bulk water vs. scraping force (mean n=3)
Graphical abstract
Moist aqueous granulation (MAG) process (left). Amount of water and their molecular states for Met
granules (right).
0
5
10
15
20
25
0.0 0.2 0.4 0.6 0.8 1.0
Scrapingforce(N)
Amount of bulk water (%)
Met + VA64
Met + PVPK12
Agglomeration by small
amounts of water
Pre-mixing of API + dry
binder
MAG process
Addition of glidant
23. 22
Tables
Table 1
Formulations used in the moist granulation experiments (% of tablet mass)
1= Agglomeration/Massing; 2=Final blending
Table 2
Granule characteristics
Description Met + VA64 Met + PVP Met + HPC Met + HPMC
Volume of added water (%) 1.0 1.5 1.0 1.5 2.0 1.0 1.5 1.0 1.5 2.0
D50(μm) 75 164 122 136 136 111 152 74 81 77
Bulk density (g/mL) 0.60 0.54 0.57 0.51 0.51 0.56 0.52 0.58 0.58 0.54
Hausner ratio 1.20 1.32 1.13 1.24 1.25 1.17 1.16 1.29 1.28 1.33
Table 3
Summary of Heckel analysis (volume of added water, 1.5 %) (Mean n=5)
Description Met API Met + VA64 Met + PVP Met + HPC Met + HPMC
True density (g/cm3
) 1.38 1.40 1.46 1.48 1.42
Yield pressure (Mpa) 226.9 113.5 167.0 157.0 219.6
Elastic recovery (%) 0.22 0.25 0.19 0.25 0.87
Process
stage
Process (volume of added water) Moist granulation (1.0%, 1.5%, 2.0%)
1
Metformin hydrocholoride 94.0 94.0 94.0 94.0
Kollodn VA 64 fine (VA64) 5.0 - - -
PVA K12 (PVP) - 5.0 - -
HPC SSL SFP (HPC) - - 5.0 -
Metocel E5LV (HPMC) - - - 5.0
2 Magnesium stearate 1.0 1.0 1.0 1.0
Total 100.0 100.0 100.0 100.0